Clinical Trial Update: Safety Study of Repeat Doses of SUSTOL in Adults [Phase 4]

View source ↗

Summary

Phase 4 safety study assessing repeat dosing of SUSTOL in adults with chemotherapy-induced nausea and vomiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• SUSTOL (granisetron)

Snippet

Sponsor: Heron Therapeutics | Conditions: Chemotherapy-Induced Nausea and Vomiting (CINV) | Phase 4 | Status: UNKNOWN